Focus Taiwan App

Taiwan grants EUA for 2nd-generation Moderna COVID-19 vaccine (update)

09/02/2022 10:10 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taiwan's Food and Drug Administration(FDA) has granted emergency use authorization (EUA) for Moderna's second-generation COVID-19 vaccines for adults aged 18 years old and above, after a meeting of experts Friday.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

    We value your privacy.
    Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.